Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

42 results about "Atelectatic lungs" patented technology

Atelectasis refers to the collapse of lung tissues which may affect a part of a lung or the whole lung itself. Usually the alveoli part collapses resulting to impaired gas exchange. Fluid retention in the lungs may also lead to the collapse of some tissues leading to the condition known as atelectasis.

Method for treating an asthma attack

A method for treating the lung during an acute episode of reversible chronic obstructive pulmonary disease such as an asthma attack. The method comprises transferring energy to an airway wall of an airway such that a diameter of the airway is increased. The energy may be transferred to the airway wall prior to, during or after an asthma attack. The energy may be transferred in an amount sufficient to temporarily or permanently increase the diameter of the airway. The method may be performed while the airway is open, closed or partially closed.
Owner:BOSTON SCI SCIMED INC

Devices for maintaining patency of surgically created channels in tissue

Devices and methods for altering gaseous flow within a lung to improve the expiration cycle of an individual, particularly individuals having chronic obstructive pulmonary disease. The methods and devices create channels in lung tissue and maintain the patency of these surgically created channels in tissue. Maintaining the patency of the channels allows air to pass directly out of the lung tissue which facilitates the exchange of oxygen ultimately into the blood and / or decompresses hyper-inflated lungs.
Owner:BRONCUS MEDICAL

Collateral ventilation bypass trap system

InactiveUS6886558B2Increase expiratory flowSpeed up the flowTracheal tubesBreathing masksCollateral ventilationObstructive Pulmonary Diseases
A long term oxygen therapy system having an oxygen supply directly linked with a patient's lung or lungs may be utilized to more efficiently treat hypoxia caused by chronic obstructive pulmonary disease such as emphysema and chronic bronchitis. The system includes an oxygen source, one or more valves and fluid carrying conduits. The fluid carrying conduits link the oxygen source to diseased sites within the patient's lungs. A collateral ventilation bypass trap system directly linked with a patient's lung or lungs may be utilized to increase the expiratory flow from the diseased lung or lungs, thereby treating another aspect of chronic obstructive pulmonary disease. The system includes a trap, a filter / one-way valve and an air carrying conduit.
Owner:PORTAERO

Non-invasive and minimally invasive denervation methods and systems for performing the same

A system and method can be used to denervate at least a portion of a bronchial tree. An energy emitter of an instrument is percutaneously delivered to a treatment site and outputs energy to damage nerve tissue of the bronchial tree. The denervation procedure can be performed without damaging non-targeted tissue. Minimally invasive methods can be used to open airways to improve lung function in subjects with COPD, asthma, or the like. Different sections of the bronchial tree can be denervated while leaving airways intact to reduce recovery times.
Owner:NUVAIRA INC

Collateral ventilation bypass trap system

InactiveUS7195017B2Speed up the flowReduce air exchangeRespiratorsBreathing masksCollateral ventilationObstructive Pulmonary Diseases
A long term oxygen therapy system having an oxygen supply directly linked with a patients lung or lungs may be utilized to more efficiently treat hypoxia caused by chronic obstructive pulmonary disease such as emphysema and chronic bronchitis. The system includes an oxygen source, one or more valves and fluid carrying conduits. The fluid carrying conduits link the oxygen source to diseased sites within the patients lungs. A collateral ventilation bypass trap system directly linked with a patient's lung or lungs may be utilized to increase the expiratory flow from the diseased lung or lungs, thereby treating another aspect of chronic obstructive pulmonary disease. The system includes a trap, a filter / one-way valve and an air carrying conduit.
Owner:PORTAERO

Long term oxygen therapy system

A long term oxygen therapy system having an oxygen supply directly linked with a patient's lung or lungs may be utilized to more efficiently treat hypoxia caused by chronic obstructive pulmonary disease such as emphysema and chronic bronchitis. The system includes an oxygen source, one or more valves and fluid carrying conduits. The fluid carrying conduits link the oxygen source to diseased sites within the patient's lungs.
Owner:PORTAERO

Endoscopic arterial pumps for treatment of cardiac insufficiency and venous pumps for right-sided cardiac support

InactiveUS7144364B2Easily weanedEasy to removeStentsSurgeryRight-SidedLung
Methods for using blood pumps to treat heart failure are disclosed. The pump is mounted on an interior of a stent, and the stent is releasably mounted on a distal end of a catheter. The distal end of the catheter is inserted into a peripheral artery and advanced to position at a region of interest within the descending aorta, the ascending aorta, or the left ventricle. The stent and the pump are released from the catheter, and the pump is activated to increase blood flow downstream of the pump. The pump can also be positioned in the vena cava or used to treat right-sided heart failure following the insertion of an LVAD, or to improve venous return in patients with varicose veins. Non-stent pumps are described for insertion between the pulmonary vein and aorta, and between the vena cava and pulmonary artery designed for use during cardiac surgery.
Owner:BARBUT DENISE R +2

Method for treating an asthma attack

A method for treating the lung during an acute episode of reversible chronic obstructive pulmonary disease such as an asthma attack. The method comprises transferring energy to an airway wall of an airway such that a diameter of the airway is increased. The energy may be transferred to the airway wall prior to, during or after an asthma attack. The energy may be transferred in an amount sufficient to temporarily or permanently increase the diameter of the airway. The method may be performed while the airway is open, closed or partially closed.
Owner:BOSTON SCI SCIMED INC

Lung reduction system

A pulmonary decompression device may be utilized to remove trapped air in the lung or lungs, thereby reducing the volume of diseased lung tissue. A lung reduction device may passively decompress the lung or lungs. In order for the system to be effective, an airtight seal between the parietal and visceral pleurae is required. Chemical pleurodesis is utilized for creating the seal.
Owner:PORTAERO

Extrapleural airway device and method

This is directed to improving the gaseous exchange in a lung of an individual and particularly, this is directed to improving the gaseous exchange in individuals having chronic obstructive pulmonary disease. It generally includes fluidly connecting the lung to an extrapleural airway such as the trachea. In one variation, a conduit is deployed to place the lung and the trachea in fluid communication which allows trapped oxygen-reduced air to pass directly out of the lung and into the trachea. Removing nonfunctional air from the lung tends to improve the gaseous exchange of oxygen into the blood and decompress hyper-inflated lungs. Sealant and biocompatible adhesives may be provided on the exterior of the conduit to prevent side flow, leaks and to otherwise prevent air from entering spaces not intended to receive air such as the pleura space.
Owner:BRONCUS MEDICAL

Extrapleural airway device and method

This is directed to improving the gaseous exchange in a lung of an individual and particularly, this is directed to improving the gaseous exchange in individuals having chronic obstructive pulmonary disease. It generally includes fluidly connecting the lung to an extrapleural airway such as the trachea. In one variation, a conduit is deployed to place the lung and the trachea in fluid communication which allows trapped oxygen-reduced air to pass directly out of the lung and into the trachea. Removing nonfunctional air from the lung tends to improve the gaseous exchange of oxygen into the blood and decompress hyper-inflated lungs. Sealant and biocompatible adhesives may be provided on the exterior of the conduit to prevent side flow, leaks and to otherwise prevent air from entering spaces not intended to receive air such as the pleura space.
Owner:BRONCUS MEDICAL

Methods and devices for providing inspiratory and expiratory flow relief during ventilation therapy

Respiratory support and / or controlled mechanical ventilation of a patient are provided. A ventilation apparatus may include a ventilator, a transtracheal prosthesis, and a respiratory relief device. The transtracheal prostheses and ventilation catheter may be arranged such that the patient can breathe freely through the upper airway and / or the tracheal prostheses. Respiratory sensors may measure a breathing rate, lung pressure, airway pressure, or a combination thereof. Pulses of gas may be provided to the patient through the ventilation catheter during inspiration. The pulses may have a first volume while the patient breathes normal and a second volume when the sensors detect a cessation of breathing or reduction in breathing volume. The second volume may be provided at 1-5 times the normal breathing rate, with a volume 25-500% times the first volume, or both.
Owner:BREATHE TECHNOLOGIES INC

Single-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease

A single-phase surgical procedure is disclosed for creating a pneumostoma to treat chronic obstructive pulmonary disease. In a single-phase technique the pleurodesis is formed at the same time as the pneumostoma and does not require a separate step. The thoracic cavity is accessed to visualize the lung, the pneumostomy catheter is inserted into the lung and then the lung is secured to the channel through the chest wall creating a sealed anastomosis which matures into a pleurodesis after the procedure.
Owner:PORTAERO

Method for treating an asthma attack

A method for treating the lung during an acute episode of reversible chronic obstructive pulmonary disease such as an asthma attack. The method comprises transferring energy to an airway wall of an airway such that a diameter of the airway is increased. The energy may be transferred to the airway wall prior to, during or after an asthma attack. The energy may be transferred in an amount sufficient to temporarily or permanently increase the diameter of the airway. The method may be performed while the airway is open, closed or partially closed.
Owner:BOSTON SCI SCIMED INC

Methods and devices for passive residual lung volume reduction and functional lung volume expansion

ActiveUS20090241964A1Residue reductionRespiratorsBronchoscopesResidual lung volumeCatheter device
The volume of a hyperinflated lung compartment is reduced by sealing a distal end of the catheter in an airway feeding the lung compartment. Air passes out of the lung compartment through a passage in the catheter while the patient exhales. A one-way flow element associated with the catheter prevents air from re-entering the lung compartment as the patient inhales. Over time, the pressure of regions surrounding the lung compartment cause it to collapse as the volume of air diminishes. Residual volume reduction effectively results in functional lung volume expansion. Optionally, the lung compartment may be sealed in order to permanently prevent air from re-entering the lung compartment. The invention further discloses a catheter with a transparent occlusion element at its tip that enables examination of the lung passageway through a viewing scope.
Owner:PULMONX

Non-invasive method and apparatus for optimizing the respiration of atelectatic lungs

Method for providing ventilatory settings with regard to the airway pressure levels of an artificial ventilator, the artificial ventilator is connected to a lung, including the steps of obtaining data samples of a gas concentration of the expired gas over a single breath; selecting a plurality of data samples from the obtained data samples; calculating a tracing value being sensitive to changes of alveolar dead space on the basis of the selected data samples; repeating steps a), b) and c) for obtaining a plurality of tracing values; and changing at least one airway pressure level of the artificial ventilator, wherein from an observation of a resulting course of the plurality of calculated tracing values an airway pressure level at which alveolar opening or lung overdistension or lung open condition or alveolar closing occurs is detected. Apparatus for providing ventilatory settings with regard to the airway pressure levels of an artificial ventilator is also disclosed.
Owner:SALVIA MEDICAL

Pulmonary vein arrhythmia diagnostic device and method for use

Devices and methods for testing a pulmonary vein to determine whether or not ablation would be effective in terminating atrial fibrillation. The devices and methods include a catheter having an expandable balloon attached to the distal end of the catheter. The balloon has pores on the distal end of the balloon for administering a fluid into the target pulmonary vein. The fluid inhibits the electrical impulses generated by the target pulmonary vein. Once the electrical impulses of the target pulmonary vein have been inhibited it can be determined whether or not the atrial fibrillation continues to occur. If the atrial fibrillation has been eliminated, then ablation or other therapy is appropriate. Thus, the devices and methods limit unnecessary treatment of a pulmonary vein.
Owner:BIOCARDIA

Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease

Surgical instruments and techniques are provided for creating a pneumostoma through the chest wall into the lung of a patient. The pneumostomy instruments and techniques may be used to create a pneumostoma which allows gases to escape from the lung through the chest wall and thereby treat chronic obstructive pulmonary disease.
Owner:PORTAERO

Intra/extra-thoracic collateral ventilation bypass system and method

A long term oxygen therapy system having an oxygen supply directly linked with a patient's lung or lungs may be utilized to more efficiently treat hypoxia caused by chronic obstructive pulmonary disease such as emphysema and chronic bronchitis. The system includes an oxygen source, one or more valves and fluid carrying conduits. The fluid carrying conduits link the oxygen source to diseased sites within the patient's lungs. A collateral ventilation bypass trap system directly linked with a patient's lung or lungs may be utilized to increase the expiratory flow from the diseased lung or lungs, thereby treating another aspect of chronic obstructive pulmonary disease. The system includes a trap, a filter / one-way valve and an air carrying conduit. In various embodiments, the system may be intrathoracic, extrathoracic or a combination thereof. In order for the system to be effective, an airtight seal between the parietal and visceral pleurae is required. Chemical pleurodesis is utilized for creating the seal.
Owner:PORTAERO

Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease

Surgical instruments and techniques are provided for creating a pneumostoma through the chest wall into the lung of a patient. The pneumostomy instruments and techniques may be used to create a pneumostoma which allows gases to escape from the lung through the chest wall and thereby treat chronic obstructive pulmonary disease.
Owner:PORTAERO

Pulmonary vein arrhythmia diagnostic device and method for use

InactiveUS6925327B2Inhibits electrical impulseLimit unnecessary treatmentStentsElectrocardiographyVeinAtrial cavity
Devices and methods for testing a pulmonary vein to determine whether or not ablation would be effective in terminating atrial fibrillation. The devices and methods include a catheter having an expandable balloon attached to the distal end of the catheter. The balloon has pores on the distal end of the balloon for administering a fluid into the target pulmonary vein. The fluid inhibits the electrical impulses generated by the target pulmonary vein. Once the electrical impulses of the target pulmonary vein have been inhibited it can be determined whether or not the atrial fibrillation continues to occur. If the atrial fibrillation has been eliminated, then ablation or other therapy is appropriate. Thus, the devices and methods limit unnecessary treatment of a pulmonary vein.
Owner:BIOCARDIA

Visceral pleura ring connector

InactiveUS7931641B2CannulasDiagnosticsCupula pleuraeLoop of Henle
A visceral pleura ring connector that may be utilized to anchor and seal the visceral pleura to a conduit or other device entering the lung from a non-native airway. The visceral pleura ring connector may be positioned around the visceral pleura and an insertion device and seal them together without having to make any holes in the pleura. The visceral pleura ring connector may be utilized with a pulmonary pleural stabilizer to hold the visceral pleura of the lung during surgical procedures involving accessing the lung or lungs of a patient directly through the lung and not the native airways.
Owner:PORTAERO

Anatomical lung volume reduction elastic bracket

The invention relates to the technical field of medical appliances, discloses a device for implementing lung volume reduction surgery, and particularly discloses an anatomical lung volume reduction elastic bracket, which can be implanted into a human lung. The anatomical lung volume reduction elastic bracket can be implanted into the tail end of the lung bronchus of a patient in a minimally invasive manner in order to eliminate the influence of tissues with severe emphysema lesion on lung function and achieve the effect of treating chronic diffuse emphysema. The anatomical lung volume reduction elastic bracket comprises a bracket body and spherical structures which are fixed to the two ends of the bracket respectively. The bracket is at a linear state at the normal temperature, and is in a U-shaped state after being released in vivo.
Owner:LEO MEDICAL

Methods and devices for providing inspiratory and expiratory flow relief during ventilation therapy

Respiratory support and / or controlled mechanical ventilation of a patient are provided. A ventilation apparatus may include a ventilator, a transtracheal prosthesis, and a respiratory relief device. The transtracheal prostheses and ventilation catheter may be arranged such that the patient can breathe freely through the upper airway and / or the tracheal prostheses. Respiratory sensors may measure a breathing rate, lung pressure, airway pressure, or a combination thereof. Pulses of gas may be provided to the patient through the ventilation catheter during inspiration. The pulses may have a first volume while the patient breathes normal and a second volume when the sensors detect a cessation of breathing or reduction in breathing volume. The second volume may be provided at 1 - 5 times the normal breathing rate, with a volume 25 - 500% times the first volume, or both.
Owner:BREATHE TECHNOLOGIES INC

Pulmonary vein arrhythmia diagnostic device and method for use

Devices and methods for testing a pulmonary vein to determine whether or not ablation would be effective in terminating atrial fibrillation. The devices and methods include a catheter having an expandable balloon attached to the distal end of the catheter. The balloon has pores on the distal end of the balloon for administering a fluid into the target pulmonary vein. The fluid inhibits the electrical impulses generated by the target pulmonary vein. Once the electrical impulses of the target pulmonary vein have been inhibited it can be determined whether or not the atrial fibrillation continues to occur. If the atrial fibrillation has been eliminated, then ablation or other therapy is appropriate. Thus, the devices and methods limit unnecessary treatment of a pulmonary vein.
Owner:BIOCARDIA

Therapeutic and surgical treatment method for providing cardiopulmonary and circulatory assist device

The present disclosure relates to a therapeutic method for improving the hemodynamics, the overall microcirculation in organs, and the restoration and preservation of deficient endothelial function in a patient, the method includes maintaining blood circulation in the patient's veins and arteries and temporarily relieving the heart of its pumping function. Relief may be accomplished by increasing the preload of the right ventricle so as to improve oxygenation of the myocardium and its contractility, reducing and diffusing regular pulsations in the proximity of the aortic root so as to improve the hemodynamics of the left ventricle of the heart, and / or mechanically stimulating the endothelium by shear forces so as to reduce systemic and pulmonary afterload.
Owner:WU GUI FU +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products